vs

Side-by-side financial comparison of Paymentus Holdings, Inc. (PAY) and RAYONIER ADVANCED MATERIALS INC. (RYAM). Click either name above to swap in a different company.

RAYONIER ADVANCED MATERIALS INC. is the larger business by last-quarter revenue ($417.5M vs $330.5M, roughly 1.3× Paymentus Holdings, Inc.). Paymentus Holdings, Inc. runs the higher net margin — 6.3% vs -5.0%, a 11.3% gap on every dollar of revenue. On growth, Paymentus Holdings, Inc. posted the faster year-over-year revenue change (28.1% vs -1.2%). Over the past eight quarters, Paymentus Holdings, Inc.'s revenue compounded faster (33.7% CAGR vs 3.8%).

Paymentus Holdings, Inc. is a leading cloud-based bill payment and customer engagement technology provider. It offers integrated digital payment solutions, billing automation tools, and self-service portals for enterprises across utilities, financial services, government, healthcare, and telecommunications segments, primarily operating in the North American market.

Rayonier Advanced Materials recently rebranded as RYAM. RYAM is an American company recognized globally for its cellulose-based technologies. Specializing in high-purity cellulose specialties, RYAM produces natural polymers extensively used in manufacturing filters, food, pharmaceuticals, and various industrial applications. Additionally, the company produces products for the paper and packaging industries. The company is publicly traded on the New York Stock Exchange under the ticker symbol ...

PAY vs RYAM — Head-to-Head

Bigger by revenue
RYAM
RYAM
1.3× larger
RYAM
$417.5M
$330.5M
PAY
Growing faster (revenue YoY)
PAY
PAY
+29.3% gap
PAY
28.1%
-1.2%
RYAM
Higher net margin
PAY
PAY
11.3% more per $
PAY
6.3%
-5.0%
RYAM
Faster 2-yr revenue CAGR
PAY
PAY
Annualised
PAY
33.7%
3.8%
RYAM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PAY
PAY
RYAM
RYAM
Revenue
$330.5M
$417.5M
Net Profit
$20.7M
$-21.1M
Gross Margin
25.4%
8.9%
Operating Margin
7.3%
2.6%
Net Margin
6.3%
-5.0%
Revenue YoY
28.1%
-1.2%
Net Profit YoY
57.2%
-31.9%
EPS (diluted)
$0.16
$-0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PAY
PAY
RYAM
RYAM
Q4 25
$330.5M
$417.5M
Q3 25
$310.7M
$352.8M
Q2 25
$280.1M
$340.0M
Q1 25
$275.2M
$356.0M
Q4 24
$257.9M
$422.5M
Q3 24
$231.6M
$401.1M
Q2 24
$197.4M
$419.0M
Q1 24
$184.9M
$387.7M
Net Profit
PAY
PAY
RYAM
RYAM
Q4 25
$20.7M
$-21.1M
Q3 25
$17.7M
$-4.5M
Q2 25
$14.7M
$-363.2M
Q1 25
$13.8M
$-32.0M
Q4 24
$13.1M
$-16.0M
Q3 24
$14.4M
$-32.6M
Q2 24
$9.4M
$11.4M
Q1 24
$7.2M
$-1.6M
Gross Margin
PAY
PAY
RYAM
RYAM
Q4 25
25.4%
8.9%
Q3 25
24.1%
9.7%
Q2 25
25.5%
7.0%
Q1 25
24.0%
6.8%
Q4 24
25.6%
8.7%
Q3 24
26.2%
10.9%
Q2 24
29.8%
11.5%
Q1 24
28.5%
9.5%
Operating Margin
PAY
PAY
RYAM
RYAM
Q4 25
7.3%
2.6%
Q3 25
6.4%
2.8%
Q2 25
5.7%
-0.4%
Q1 25
5.7%
-4.2%
Q4 24
5.5%
2.6%
Q3 24
5.2%
-4.2%
Q2 24
5.2%
6.7%
Q1 24
4.5%
4.4%
Net Margin
PAY
PAY
RYAM
RYAM
Q4 25
6.3%
-5.0%
Q3 25
5.7%
-1.3%
Q2 25
5.3%
-106.8%
Q1 25
5.0%
-9.0%
Q4 24
5.1%
-3.8%
Q3 24
6.2%
-8.1%
Q2 24
4.7%
2.7%
Q1 24
3.9%
-0.4%
EPS (diluted)
PAY
PAY
RYAM
RYAM
Q4 25
$0.16
$-0.33
Q3 25
$0.14
$-0.07
Q2 25
$0.11
$-5.44
Q1 25
$0.11
$-0.49
Q4 24
$0.11
$-0.25
Q3 24
$0.11
$-0.49
Q2 24
$0.07
$0.17
Q1 24
$0.06
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PAY
PAY
RYAM
RYAM
Cash + ST InvestmentsLiquidity on hand
$320.9M
$75.4M
Total DebtLower is stronger
$758.1M
Stockholders' EquityBook value
$560.4M
$316.6M
Total Assets
$667.9M
$1.8B
Debt / EquityLower = less leverage
2.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PAY
PAY
RYAM
RYAM
Q4 25
$320.9M
$75.4M
Q3 25
$287.9M
$77.0M
Q2 25
$266.4M
$70.7M
Q1 25
$245.8M
$129.9M
Q4 24
$205.9M
$125.2M
Q3 24
$187.5M
$136.1M
Q2 24
$188.8M
$114.1M
Q1 24
$180.1M
$54.6M
Total Debt
PAY
PAY
RYAM
RYAM
Q4 25
$758.1M
Q3 25
$763.5M
Q2 25
$720.4M
Q1 25
$707.0M
Q4 24
$706.4M
Q3 24
$747.7M
Q2 24
$752.8M
Q1 24
$755.6M
Stockholders' Equity
PAY
PAY
RYAM
RYAM
Q4 25
$560.4M
$316.6M
Q3 25
$537.4M
$338.2M
Q2 25
$516.7M
$342.3M
Q1 25
$500.4M
$688.1M
Q4 24
$485.6M
$713.9M
Q3 24
$468.8M
$732.7M
Q2 24
$451.6M
$755.1M
Q1 24
$439.4M
$741.8M
Total Assets
PAY
PAY
RYAM
RYAM
Q4 25
$667.9M
$1.8B
Q3 25
$644.4M
$1.8B
Q2 25
$609.5M
$1.8B
Q1 25
$590.9M
$2.1B
Q4 24
$576.2M
$2.1B
Q3 24
$552.9M
$2.2B
Q2 24
$527.7M
$2.2B
Q1 24
$514.0M
$2.1B
Debt / Equity
PAY
PAY
RYAM
RYAM
Q4 25
2.39×
Q3 25
2.26×
Q2 25
2.10×
Q1 25
1.03×
Q4 24
0.99×
Q3 24
1.02×
Q2 24
1.00×
Q1 24
1.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PAY
PAY
RYAM
RYAM
Operating Cash FlowLast quarter
$45.1M
$32.3M
Free Cash FlowOCF − Capex
$45.0M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
2.18×
TTM Free Cash FlowTrailing 4 quarters
$161.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PAY
PAY
RYAM
RYAM
Q4 25
$45.1M
$32.3M
Q3 25
$35.1M
$-17.8M
Q2 25
$31.5M
$-30.2M
Q1 25
$50.4M
$39.6M
Q4 24
$27.9M
$54.9M
Q3 24
$6.7M
$49.8M
Q2 24
$18.0M
$87.6M
Q1 24
$11.0M
$11.3M
Free Cash Flow
PAY
PAY
RYAM
RYAM
Q4 25
$45.0M
Q3 25
$35.0M
Q2 25
$31.4M
Q1 25
$50.4M
Q4 24
$27.8M
Q3 24
$6.7M
Q2 24
$17.8M
Q1 24
$10.8M
FCF Margin
PAY
PAY
RYAM
RYAM
Q4 25
13.6%
Q3 25
11.3%
Q2 25
11.2%
Q1 25
18.3%
Q4 24
10.8%
Q3 24
2.9%
Q2 24
9.0%
Q1 24
5.9%
Capex Intensity
PAY
PAY
RYAM
RYAM
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
PAY
PAY
RYAM
RYAM
Q4 25
2.18×
Q3 25
1.98×
Q2 25
2.14×
Q1 25
3.65×
Q4 24
2.12×
Q3 24
0.47×
Q2 24
1.93×
7.69×
Q1 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PAY
PAY

Payment Transaction Processing Revenue$326.9M99%
Other$3.5M1%

RYAM
RYAM

Cellulose Specialties$249.6M60%
Other$86.2M21%
Paperboard$44.2M11%
High Yield Pulp$28.3M7%
Biomaterials$9.2M2%

Related Comparisons